Literature DB >> 17929297

Infliximab-induced lupus-like syndrome associated with autoimmune hepatitis.

M Marques, F Magro, H Cardoso, F Carneiro, R Portugal, J Lopes, C Costa Santos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17929297     DOI: 10.1002/ibd.20293

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  21 in total

Review 1.  Autoimmune hepatitis induced by adalimumab with successful switch to abatacept.

Authors:  A Grasland; R Sterpu; S Boussoukaya; I Mahe
Journal:  Eur J Clin Pharmacol       Date:  2011-12-29       Impact factor: 2.953

2.  What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers?

Authors:  Mark Lebwohl
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

Review 3.  Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

Review 4.  Infliximab-related hepatitis: a case study and literature review.

Authors:  Francisco Colina; Aída Molero; Begoña Casís; Pilar Martínez-Montiel
Journal:  Dig Dis Sci       Date:  2013-05-05       Impact factor: 3.199

Review 5.  Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.

Authors:  Ersilia M DeFilippis; Sonal Kumar
Journal:  Dig Dis Sci       Date:  2015-05-22       Impact factor: 3.199

6.  Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases.

Authors:  Susana Rodrigues; Susana Lopes; Fernando Magro; Hélder Cardoso; Ana Maria Horta e Vale; Margarida Marques; Eva Mariz; Miguel Bernardes; Joanne Lopes; Fátima Carneiro; Guilherme Macedo
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 7.  Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literature.

Authors:  Ora Shovman; Shalev Tamar; Howard Amital; Abdulla Watad; Yehuda Shoenfeld
Journal:  Clin Rheumatol       Date:  2017-10-23       Impact factor: 2.980

Review 8.  Liver injury from tumor necrosis factor-α antagonists: analysis of thirty-four cases.

Authors:  Marwan Ghabril; Herbert L Bonkovsky; Clarissa Kum; Tim Davern; Paul H Hayashi; David E Kleiner; Jose Serrano; Jim Rochon; Robert J Fontana; Maurizio Bonacini
Journal:  Clin Gastroenterol Hepatol       Date:  2013-01-17       Impact factor: 11.382

9.  Toxic hepatitis induced by infliximab in a patient with rheumatoid arthritis with no relapse after switching to etanercept.

Authors:  K M Carlsen; L Riis; O R Madsen
Journal:  Clin Rheumatol       Date:  2009-04-16       Impact factor: 2.980

10.  Infliximab for the treatment of refractory scleritis.

Authors:  Priyanka Doctor; Amyna Sultan; Sana Syed; William Christen; Pooja Bhat; C Stephen Foster
Journal:  Br J Ophthalmol       Date:  2009-12-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.